Global Breast Cancer Patient Insights and Epidemiology - 2016

  • ID: 3692178
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Breast Cancer Patient Insights and Epidemiology – 2016, provides insights into total Breast Cancer patients on drug therapies in top 7 markets, Breast Cancer treatable patients, and Breast Cancer epidemiology in top 7 markets. Epipatients conducted an online survey with Breast Cancer specialists, oncologists, and Breast Cancer patients to identify the Breast Cancer patients in top 7 markets who were treated by drug therapies. The research also identifies total Breast Cancer patients’ on drug therapies by Breast Cancer stages.
Breast cancer patients take chemotherapies, hormone therapies, and targeted therapies as a part of their treatment. This study accurately determines and forecast Breast Cancer patients who were on drug therapies in a given year. This research also provides insights into Breast Cancer epidemiology including Breast Cancer incidence and Breast Cancer prevalence by Breast Cancer stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Breast Cancer Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Breast Cancer Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Breast Cancer Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Breast Cancer Patients on drug therapies by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Breast Cancer market potential, Breast Cancer drug therapies market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Breast Cancer Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on drug therapies
3. Breast Cancer Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on drug therapies
4. Breast Cancer Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on drug therapies
5. Breast Cancer Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on drug therapies
6. Breast Cancer Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on drug therapies
7. Breast Cancer Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on drug therapies
8. Breast Cancer Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on drug therapies
9. Breast Cancer Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on drug therapies
10. Glossary

1. Breast Cancer Incidence by Stages, Global, 2010 - 2025
2. Breast Cancer Prevalence by Stages, Global, 2010 - 2025
3. Breast Cancer Treatable Patients by Stages, Global, 2010 - 2025
4. Total Breast Cancer Patients on drug therapies by Stages, Global, 2010 – 2025
5. Breast Cancer Incidence by Stages, Germany, 2010 - 2025
6. Breast Cancer Prevalence by Stages, Germany, 2010 - 2025
7. Breast Cancer Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Breast Cancer Patients on drug therapies by Stages, Germany, 2010 - 2025
9. Breast Cancer Incidence by Stages, France, 2010 - 2025
10. Breast Cancer Prevalence by Stages, France, 2010 - 2025
11. Breast Cancer Treatable Patients by Stages, France, 2010 - 2025
12. Total Breast Cancer Patients on drug therapies by Stages, France, 2010 - 2025
13. Breast Cancer Incidence by Stages, Italy, 2010 - 2025
14. Breast Cancer Prevalence by Stages, Italy, 2010 - 2025
15. Breast Cancer Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Breast Cancer Patients on drug therapies by Stages, Italy, 2010 - 2025
17. Breast Cancer Incidence by Stages, Spain, 2010 - 2025
18. Breast Cancer Prevalence by Stages, Spain, 2010 - 2025
19. Breast Cancer Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Breast Cancer Patients on drug therapies by Stages, Spain, 2010 - 2025
21. Breast Cancer Incidence by Stages, UK, 2010 - 2025
22. Breast Cancer Prevalence by Stages, UK, 2010 - 2025
23. Breast Cancer Treatable Patients by Stages, UK, 2010 - 2025
24. Total Breast Cancer Patients on drug therapies by Stages, UK, 2010 – 2025
25. Breast Cancer Incidence by Stages, Japan, 2010 - 2025
26. Breast Cancer Prevalence by Stages, Japan, 2010 - 2025
27. Breast Cancer Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Breast Cancer Patients on drug therapies by Stages, Japan, 2010 – 2025
29. Breast Cancer Incidence by Stages, US, 2010 - 2025
30. Breast Cancer Prevalence by Stages, US, 2010 - 2025
31. Breast Cancer Treatable Patients by Stages, US 2010 - 2025
32. Total Breast Cancer Patients on drug therapies by Stages, US, 2010 - 2025

1. Breast Cancer Incidence, Global, 2010 – 2025
2. Breast Cancer Incidence – Stage I, Global, 2010 – 2025
3. Breast Cancer Incidence – Stage II, Global, 2010 - 2025
4. Breast Cancer Incidence – Stage III, Global, 2010 - 2025
5. Breast Cancer Incidence – Stage IV, Global, 2010 – 2025
6. Breast Cancer Prevalence, Global, 2010 - 2025
7. Breast Cancer Prevalence – Stage I, Global, 2010 – 2025
8. Breast Cancer Prevalence – Stage II, Global, 2010 - 2025
9. Breast Cancer Prevalence – Stage III, Global, 2010 - 2025
10. Breast Cancer Prevalence – Stage IV, Global, 2010 - 2025
11. Breast Cancer Treatable Patients, Global, 2010 - 2025
12. Breast Cancer Treatable Patients – Stage I, Global, 2010 – 2025
13. Breast Cancer Treatable Patients – Stage II, Global, 2010 - 2025
14. Breast Cancer Treatable Patients – Stage III, Global, 2010 - 2025
15. Breast Cancer Treatable Patients – Stage IV, Global, 2010 - 2025
16. Breast Cancer Patients on drug therapies, Global, 2010 - 2025
17. Total Breast Cancer Patients on drug therapies – Stage I, Global, 2010 – 2025
18. Total Breast Cancer Patients on drug therapies – Stage II, Global, 2010 – 2025
19. Total Breast Cancer Patients on drug therapies – Stage III, Global, 2010 – 2025
20. Total Breast Cancer Patients on drug therapies – Stage IV, Global, 2010 – 2025
21. Breast Cancer Incidence by Stages, Germany, 2010 – 2025
22. Breast Cancer Prevalence by Stages, Germany, 2010 – 2025
23. Breast Cancer Treatable Patients by Stages, Germany, 2010 – 2025
24. Breast Cancer Patients on drug therapies, Germany, 2010 - 2015
25. Breast Cancer Incidence by Stages, France, 2010 – 2025
26. Breast Cancer Prevalence by Stages, France, 2010 – 2025
27. Breast Cancer Treatable Patients by Stages, France, 2010 – 2025
28. Breast Cancer Patients on drug therapies, France, 2010 – 2025
29. Breast Cancer Incidence by Stages, Italy, 2010 – 2025
30. Breast Cancer Prevalence by Stages, Italy, 2010 – 2025
31. Breast Cancer Treatable Patients by Stages, Italy, 2010 – 2025
32. Breast Cancer Patients on drug therapies, Italy, 2010 – 2025
33. Breast Cancer Incidence by Stages, Spain, 2010 – 2025
34. Breast Cancer Prevalence by Stages, Spain, 2010 – 2025
35. Breast Cancer Treatable Patients by Stages, Spain, 2010 – 2025
36. Breast Cancer Patients on drug therapies, Spain, 2010 - 2015
37. Breast Cancer Incidence by Stages, UK, 2010 – 2025
38. Breast Cancer Prevalence by Stages, UK, 2010 – 2025
39. Breast Cancer Treatable Patients by Stages, UK, 2010 – 2025
40. Breast Cancer Patients on drug therapies, UK, 2010 – 2025
41. Breast Cancer Incidence by Stages, Japan, 2010 – 2025
42. Breast Cancer Prevalence by Stages, Japan, 2010 – 2025
43. Breast Cancer Treatable Patients by Stages, Japan, 2010 – 2025
44. Breast Cancer Patients on drug therapies, Japan, 2010 – 2025
45. Breast Cancer Incidence by Stages, US, 2010 – 2025
46. Breast Cancer Prevalence by Stages, US, 2010 – 2025
47. Breast Cancer Treatable Patients by Stages, US, 2010 – 2025
48. Breast Cancer Patients on drug therapies, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll